Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6119)
All Articles published online
|
Publishing Process of This Article
|
Jun 6, 2019 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen YC, Li CY, Tsai SJ, Chen YC. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals. World J Clin Cases 2019; 7(11): 1270-1281 [PMID: 31236391 DOI: 10.12998/wjcc.v7.i11.1270] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i11/1270.htm |
| Number | Citing Articles |
| 1 |
Hsu-Heng Yen, Yang-Yuan Chen, Jun-Hung Lai, Hung-Ming Chen, Chih-Ta Yao, Siou-Ping Huang, I-Ling Liu, Ya-Huei Zeng, Fang-Chi Yang, Fu-Yuan Siao, Mei-Wen Chen, Pei-Yuan Su. Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis. Journal of Clinical Medicine 2022; 11(7): 1853 doi: 10.3390/jcm11071853
|
| 2 |
Joan Martínez-Campreciós, Mar Riveiro-Barciela, Raquel Muñoz-Gómez, María-Carlota Londoño, Mercé Roget, Miguel Ángel Serra, Desamparados Escudero-García, Laura Purchades, Manuel Rodríguez, Juan E. Losa-García, María L. Gutiérrez, Isabel Carmona, Javier García-Samaniego, Luís Morano, Ignacio Martín-Granizo, Marta Montero-Alonso, Martín Prieto, Manuel Delgado, Natalia Ramos, María A. Azancot, Francisco Rodríguez-Frías, Maria Buti. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy. Gastroenterología y Hepatología 2023; 46(8): 594 doi: 10.1016/j.gastrohep.2022.12.004
|
| 3 |
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Ezequiel Ridruejo. Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysis. Nefrología (English Edition) 2021; 41(5): 578 doi: 10.1016/j.nefroe.2021.11.011
|
| 4 |
Patricio E. Ray, Asha Moudgil, Aditi Sinha. Pediatric Nephrology. 2022; : 707 doi: 10.1007/978-3-030-52719-8_101
|
| 5 |
Chien‐Hsueh Tung, Chung‐Yi Li, Yen‐Chun Chen, Yi‐Chun Chen. Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren’s syndrome: 15‐year analysis of the national database of Taiwan. Journal of Viral Hepatitis 2021; 28(5): 809 doi: 10.1111/jvh.13481
|
| 6 |
Joan Martínez-Campreciós, Mar Riveiro-Barciela, Raquel Muñoz-Gómez, María-Carlota Londoño, Mercé Roget, Miguel Ángel Serra, Desamparados Escudero-García, Laura Purchades, Manuel Rodríguez, Juan E. Losa-García, María L. Gutiérrez, Isabel Carmona, Javier García-Samaniego, Luís Morano, Ignacio Martín-Granizo, Marta Montero-Alonso, Martín Prieto, Manuel Delgado, Natalia Ramos, María A. Azancot, Francisco Rodríguez-Frías, Maria Buti. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy. Gastroenterología y Hepatología (English Edition) 2023; 46(8): 594 doi: 10.1016/j.gastre.2022.12.004
|
| 7 |
Patricio E. Ray, Asha Moudgil, Aditi Sinha. Pediatric Nephrology. 2021; : 1 doi: 10.1007/978-3-642-27843-3_101-1
|
| 8 |
Fabrizio Fabrizi, Federica Tripodi, Roberta Cerutti, Luca Nardelli, Carlo M. Alfieri, Maria F. Donato, Giuseppe Castellano. Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease. Viruses 2022; 14(11): 2570 doi: 10.3390/v14112570
|
| 9 |
Renin Chang, Ming Li Chen, Cheng-Li Lin, Yao-Min Hung, James Cheng-Chung Wei. Association of Infection With Human Papillomavirus and Development of End-Stage Kidney Disease in Taiwan. JAMA Network Open 2020; 3(10): e2022107 doi: 10.1001/jamanetworkopen.2020.22107
|
| 10 |
Pei-Yuan Su, Yang-Yuan Chen, Jun-Hung Lai, Hung-Ming Chen, Chih-Ta Yao, I-Ling Liu, Ya-Huei Zeng, Siou-Ping Huang, Yu-Chun Hsu, Shun-Sheng Wu, Fu-Yuan Siao, Hsu-Heng Yen. Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective Study. Journal of Clinical Medicine 2021; 10(22): 5236 doi: 10.3390/jcm10225236
|
| 11 |
Hsu-Heng Yen, Pei-Yuan Su, I-Ling Liu, Ya-Yuei Zeng, Siou-Ping Huang, Yu-Chun Hsu, Chia-Wei Yang, Yang-Yuan Chen. Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patients. PeerJ 2021; 9: e10944 doi: 10.7717/peerj.10944
|
| 12 |
Giovana Rossato, Cristiane Valle Tovo, Paulo Roberto Lerias de Almeida. Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes. The Brazilian Journal of Infectious Diseases 2020; 24(1): 25 doi: 10.1016/j.bjid.2019.10.011
|
| 13 |
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Ezequiel Ridruejo. Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysis. Nefrología 2021; 41(5): 578 doi: 10.1016/j.nefro.2021.01.008
|
| 14 |
Hsu-Heng Yen, Pei-Yuan Su, Ya-Huei Zeng, I-Ling Liu, Siou-Ping Huang, Yu-Chun Hsu, Yang-Yuan Chen, Chia-Wei Yang, Shun-Sheng Wu, Kun-Ching Chou, Tatsuo Kanda. Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting. PLOS ONE 2020; 15(8): e0237582 doi: 10.1371/journal.pone.0237582
|